Drug Type Fusion protein |
Synonyms- |
Target |
Mechanism TRAIL stimulants(Tumor necrosis factor ligand superfamily member 10 stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diffuse Large B-Cell Lymphoma | Preclinical | PL | 31 Oct 2022 |